pipette
ENEnglish

Tuning intracellular immunity by Nodamura virus B2 protein enhances self-amplifying RNA activity

Raul Y. Sanchez-David, Josephine Nemegeer, Hoàng Duy Lê, Eva Žusinaite, Livia Spiga, Amanda Gonçalves, John S. Tregoning, Andres Merits, Pierre V. Maillard

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Self-amplifying RNA (saRNA) offers a powerful approach for vaccine development, as its replicative nature within cells provides prolonged antigen expression together with self-adjuvanticity. However, its potency is often limited by innate immune responses, particularly those triggered by intracellular double-stranded RNA (dsRNA), highlighting the need for strategies that can boost saRNA efficacy without compromising its immunostimulatory properties. Here we show that the cis-expression of the Nodamura virus (NoV) B2 protein markedly enhances saRNA-driven transgene expression by alleviating key cell-intrinsic antiviral effectors. In stem cells, NoV B2 limits the accumulation of Dicer-generated viral small RNAs, consistent with suppression of antiviral RNA interference, while in somatic cells, it prevents protein kinase R (PKR)-driven translational shutdown. NoV B2 sequesters dsRNA at the cell periphery, shielding it from antiviral effectors without suppressing type I interferon induction or signalling, thereby preserving saRNA's immunostimulatory properties, while enhancing its transgene expression potential. These findings reveal a strategy to overcome intracellular antiviral restriction of saRNA while preserving adjuvanticity, with implications for the design of more effective saRNA-based vaccines and therapeutics.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 30 de septiembre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-77816-2